Eton Pharmaceuticals Inc (ETON)
NASDAQ:ETON
US Market
Advertisement

Eton Pharmaceuticals (ETON) Revenue

Compare
507 Followers

Eton Pharmaceuticals Revenue

Eton Pharmaceuticals had a revenue of 22.46M in the quarter ending Sep 30, 2025, with 18.65%. This bring the company's revenue in the last twelve months to 70.32M, Decreased 20.86%. In the fiscal year ending Dec 31, 2024, Eton Pharmaceuticals had annual revenue of 39.01M with 23.29% growth.
Revenue (ttm)
70.32M
Revenue Growth
102.77%
P/S Ratio
12.00
Revenue/Employee
$1,258,419
Employees
31
Market Cap
$468.23M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
39.01M7.37M+123.29%
Dec 31, 2023
31.64M10.39M+148.90%
Dec 31, 2022
21.25M-581.00K+97.34%
Dec 31, 2021
21.83M21.79M+55,980.92%
Dec 31, 2020
39.00K-920.00K+4.07%
Dec 31, 2019
959.00K-95,900,000.00%
Dec 31, 2018
Dec 31, 2017
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis